Home/Investors/Deerfield Management

Deerfield Management

Biotech Investor · 11 portfolio companies

Portfolio

11

Focus Areas

11

Top Stage

Pre-clinical

Investment Focus

Oncology Immunology Cardiovascular Disease Atherosclerosis Neurosurgery Cardiovascular Coronary Artery Disease Heart Failure Rare Genetic Diseases Metabolic Disorders Neurological Disorders

Portfolio Companies

Company	Stage	Valuation	Focus
Ribon Therapeutics	phase-2	—	Oncology, Immunology
Bitterroot Bio	Pre-clinical	—	Cardiovascular Disease, Atherosclerosis
Imris, Deerfield Imaging	Commercial	—	Neurosurgery
Excelsior Sciences	Pre-clinical	—	—
SpectraWAVE	Commercial	—	Cardiovascular, Coronary Artery Disease
Aviko Radiopharmaceuticals	Pre-clinical	—	Oncology
VeritaScience	Pre-clinical	—	Oncology, Immunology
Axon Therapies	Phase 2	—	Cardiovascular Disease, Heart Failure
Homology Medicines	Phase 2	—	Rare Genetic Diseases, Metabolic Disorders
FogPharma	phase-1	—	Oncology
GenoDx	commercial	—	Oncology

Frequent Co-Investors

OrbiMed1 shared Cormorant Asset Management1 shared Atlas Venture1 shared ARCH Venture Partners1 shared Euclidean Capital1 shared Novo Holdings1 shared Johnson & Johnson Innovation – JJDC1 shared Sofinnova Partners1 shared